The Filings Report

Molina Healthcare, Inc.

MOHNYSECIK 1179929Healthcare / Healthcare Plansfiscal year ends December67 quarters since 2010

Revenue, Q3 FY2026
$11.1B
−3.4% on Q3 FY2025
Net income
$38M
−51.9% on Q3 FY2025
Free cash flow
−$196M
−20.2% on Q3 FY2025
Diluted EPS
$0.73
−51.7% on Q3 FY2025
Revenue, TTM
$44.1B
trailing four quarters
Net margin, TTM
-0.1%
net income −$48M
Free cash flow, TTM
$238M
$331M less $93M capex
Cash and equivalents
$4.5B
long-term debt $3.8B, Sep 30, 2026
Shares, 12-month change
+1.6%
52M shares, Sep 30, 2026
Buybacks, TTM
$0
0.0% of market value
Dividends, TTM
—
no yield
Market value
$10.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 22, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Molina Healthcare, Inc. reported revenue of $11.1B, −3.4% on Q3 FY2025, and net income of $38M (−51.9%). Operating margin was 1.0%. Free cash flow, operating cash flow less capital expenditures, was −$196M (−$159M less $37M). Diluted earnings per share were $0.73.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

MOH daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $212.84 · H $219.00 · L $206.62 · C $208.99 · −3.53% on the dayOver the range: +42.05%, Nov 7, 2025 to Nov 6, 2026
$114$148$183$218$252Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 22, 2026.

Revenue and net incomeRevenueNet income
−$5B$0$5B$10B$15BQ4'22, Revenue: $8.2BQ4'22, Net income: $56MQ4'22Q1'23, Revenue: $8.1BQ1'23, Net income: $321MQ1'23Q2'23, Revenue: $8.3BQ2'23, Net income: $309MQ2'23Q3'23, Revenue: $8.5BQ3'23, Net income: $245MQ3'23Q4'23, Revenue: $9.0BQ4'23, Net income: $216MQ4'23Q1'24, Revenue: $9.9BQ1'24, Net income: $301MQ1'24Q2'24, Revenue: $9.9BQ2'24, Net income: $301MQ2'24Q3'24, Revenue: $10.3BQ3'24, Net income: $326MQ3'24Q4'24, Revenue: $10.5BQ4'24, Net income: $251MQ4'24Q1'25, Revenue: $11.1BQ1'25, Net income: $298MQ1'25Q2'25, Revenue: $11.4BQ2'25, Net income: $255MQ2'25Q3'25, Revenue: $11.5BQ3'25, Net income: $79MQ3'25Q4'25, Revenue: $11.4BQ4'25, Net income: −$160MQ4'25Q1'26, Revenue: $10.8BQ1'26, Net income: $14MQ1'26Q2'26, Revenue: $10.9BQ2'26, Net income: $60MQ2'26Q3'26, Revenue: $11.1BQ3'26, Net income: $38MQ3'26−$5B$0$5B$10B$15BQ4'22, Revenue: $8.2BQ4'22, Net income: $56MQ4'22Q1'23, Revenue: $8.1BQ1'23, Net income: $321MQ1'23Q2'23, Revenue: $8.3BQ2'23, Net income: $309MQ2'23Q3'23, Revenue: $8.5BQ3'23, Net income: $245MQ3'23Q4'23, Revenue: $9.0BQ4'23, Net income: $216MQ4'23Q1'24, Revenue: $9.9BQ1'24, Net income: $301MQ1'24Q2'24, Revenue: $9.9BQ2'24, Net income: $301MQ2'24Q3'24, Revenue: $10.3BQ3'24, Net income: $326MQ3'24Q4'24, Revenue: $10.5BQ4'24, Net income: $251MQ4'24Q1'25, Revenue: $11.1BQ1'25, Net income: $298MQ1'25Q2'25, Revenue: $11.4BQ2'25, Net income: $255MQ2'25Q3'25, Revenue: $11.5BQ3'25, Net income: $79MQ3'25Q4'25, Revenue: $11.4BQ4'25, Net income: −$160MQ4'25Q1'26, Revenue: $10.8BQ1'26, Net income: $14MQ1'26Q2'26, Revenue: $10.9BQ2'26, Net income: $60MQ2'26Q3'26, Revenue: $11.1BQ3'26, Net income: $38MQ3'26−$5B$0$5B$10B$15BQ4'22, Revenue: $8.2BQ4'22, Net income: $56MQ1'23, Revenue: $8.1BQ1'23, Net income: $321MQ1'23Q2'23, Revenue: $8.3BQ2'23, Net income: $309MQ3'23, Revenue: $8.5BQ3'23, Net income: $245MQ3'23Q4'23, Revenue: $9.0BQ4'23, Net income: $216MQ1'24, Revenue: $9.9BQ1'24, Net income: $301MQ1'24Q2'24, Revenue: $9.9BQ2'24, Net income: $301MQ3'24, Revenue: $10.3BQ3'24, Net income: $326MQ3'24Q4'24, Revenue: $10.5BQ4'24, Net income: $251MQ1'25, Revenue: $11.1BQ1'25, Net income: $298MQ1'25Q2'25, Revenue: $11.4BQ2'25, Net income: $255MQ3'25, Revenue: $11.5BQ3'25, Net income: $79MQ3'25Q4'25, Revenue: $11.4BQ4'25, Net income: −$160MQ1'26, Revenue: $10.8BQ1'26, Net income: $14MQ1'26Q2'26, Revenue: $10.9BQ2'26, Net income: $60MQ3'26, Revenue: $11.1BQ3'26, Net income: $38MQ3'26

Net income losses drawn in red.

Free cash flow
−$1.0B−$500M$0$500M$1.0B$1.5BQ4'22, Free cash flow: −$222MQ4'22Q1'23, Free cash flow: $884MQ1'23Q2'23, Free cash flow: $456MQ2'23Q3'23, Free cash flow: $923MQ3'23Q4'23, Free cash flow: −$685MQ4'23Q1'24, Free cash flow: $187MQ1'24Q2'24, Free cash flow: −$246MQ2'24Q3'24, Free cash flow: $838MQ3'24Q4'24, Free cash flow: −$235MQ4'24Q1'25, Free cash flow: $168MQ1'25Q2'25, Free cash flow: −$344MQ2'25Q3'25, Free cash flow: −$163MQ3'25Q4'25, Free cash flow: −$297MQ4'25Q1'26, Free cash flow: $1.1BQ1'26Q2'26, Free cash flow: −$324MQ2'26Q3'26, Free cash flow: −$196MQ3'26−$1.0B−$500M$0$500M$1.0B$1.5BQ4'22, Free cash flow: −$222MQ4'22Q1'23, Free cash flow: $884MQ1'23Q2'23, Free cash flow: $456MQ2'23Q3'23, Free cash flow: $923MQ3'23Q4'23, Free cash flow: −$685MQ4'23Q1'24, Free cash flow: $187MQ1'24Q2'24, Free cash flow: −$246MQ2'24Q3'24, Free cash flow: $838MQ3'24Q4'24, Free cash flow: −$235MQ4'24Q1'25, Free cash flow: $168MQ1'25Q2'25, Free cash flow: −$344MQ2'25Q3'25, Free cash flow: −$163MQ3'25Q4'25, Free cash flow: −$297MQ4'25Q1'26, Free cash flow: $1.1BQ1'26Q2'26, Free cash flow: −$324MQ2'26Q3'26, Free cash flow: −$196MQ3'26−$1.0B−$500M$0$500M$1.0B$1.5BQ4'22, Free cash flow: −$222MQ1'23, Free cash flow: $884MQ1'23Q2'23, Free cash flow: $456MQ3'23, Free cash flow: $923MQ3'23Q4'23, Free cash flow: −$685MQ1'24, Free cash flow: $187MQ1'24Q2'24, Free cash flow: −$246MQ3'24, Free cash flow: $838MQ3'24Q4'24, Free cash flow: −$235MQ1'25, Free cash flow: $168MQ1'25Q2'25, Free cash flow: −$344MQ3'25, Free cash flow: −$163MQ3'25Q4'25, Free cash flow: −$297MQ1'26, Free cash flow: $1.1BQ1'26Q2'26, Free cash flow: −$324MQ3'26, Free cash flow: −$196MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ4'22, Cash and equivalents: $4.0BQ4'22, Long-term debt: $2.2BQ4'22Q1'23, Cash and equivalents: $4.6BQ1'23, Long-term debt: $2.2BQ1'23Q2'23, Cash and equivalents: $4.9BQ2'23, Long-term debt: $2.2BQ2'23Q3'23, Cash and equivalents: $5.6BQ3'23, Long-term debt: $2.2BQ3'23Q4'23, Cash and equivalents: $4.8BQ4'23, Long-term debt: $2.2BQ4'23Q1'24, Cash and equivalents: $4.5BQ1'24, Long-term debt: $2.2BQ1'24Q2'24, Cash and equivalents: $4.4BQ2'24, Long-term debt: $2.2BQ2'24Q3'24, Cash and equivalents: $4.7BQ3'24, Long-term debt: $2.3BQ3'24Q4'24, Cash and equivalents: $4.7BQ4'24, Long-term debt: $2.9BQ4'24Q1'25, Cash and equivalents: $4.9BQ1'25, Long-term debt: $3.6BQ1'25Q2'25, Cash and equivalents: $4.5BQ2'25, Long-term debt: $3.4BQ2'25Q3'25, Cash and equivalents: $4.2BQ3'25, Long-term debt: $3.7BQ3'25Q4'25, Cash and equivalents: $4.2BQ4'25, Long-term debt: $3.8BQ4'25Q1'26, Cash and equivalents: $5.3BQ1'26, Long-term debt: $3.8BQ1'26Q2'26, Cash and equivalents: $5.0BQ2'26, Long-term debt: $3.8BQ2'26Q3'26, Cash and equivalents: $4.5BQ3'26, Long-term debt: $3.8BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $4.0BQ4'22, Long-term debt: $2.2BQ4'22Q1'23, Cash and equivalents: $4.6BQ1'23, Long-term debt: $2.2BQ1'23Q2'23, Cash and equivalents: $4.9BQ2'23, Long-term debt: $2.2BQ2'23Q3'23, Cash and equivalents: $5.6BQ3'23, Long-term debt: $2.2BQ3'23Q4'23, Cash and equivalents: $4.8BQ4'23, Long-term debt: $2.2BQ4'23Q1'24, Cash and equivalents: $4.5BQ1'24, Long-term debt: $2.2BQ1'24Q2'24, Cash and equivalents: $4.4BQ2'24, Long-term debt: $2.2BQ2'24Q3'24, Cash and equivalents: $4.7BQ3'24, Long-term debt: $2.3BQ3'24Q4'24, Cash and equivalents: $4.7BQ4'24, Long-term debt: $2.9BQ4'24Q1'25, Cash and equivalents: $4.9BQ1'25, Long-term debt: $3.6BQ1'25Q2'25, Cash and equivalents: $4.5BQ2'25, Long-term debt: $3.4BQ2'25Q3'25, Cash and equivalents: $4.2BQ3'25, Long-term debt: $3.7BQ3'25Q4'25, Cash and equivalents: $4.2BQ4'25, Long-term debt: $3.8BQ4'25Q1'26, Cash and equivalents: $5.3BQ1'26, Long-term debt: $3.8BQ1'26Q2'26, Cash and equivalents: $5.0BQ2'26, Long-term debt: $3.8BQ2'26Q3'26, Cash and equivalents: $4.5BQ3'26, Long-term debt: $3.8BQ3'26$0$2B$4B$6BQ4'22, Cash and equivalents: $4.0BQ4'22, Long-term debt: $2.2BQ1'23, Cash and equivalents: $4.6BQ1'23, Long-term debt: $2.2BQ1'23Q2'23, Cash and equivalents: $4.9BQ2'23, Long-term debt: $2.2BQ3'23, Cash and equivalents: $5.6BQ3'23, Long-term debt: $2.2BQ3'23Q4'23, Cash and equivalents: $4.8BQ4'23, Long-term debt: $2.2BQ1'24, Cash and equivalents: $4.5BQ1'24, Long-term debt: $2.2BQ1'24Q2'24, Cash and equivalents: $4.4BQ2'24, Long-term debt: $2.2BQ3'24, Cash and equivalents: $4.7BQ3'24, Long-term debt: $2.3BQ3'24Q4'24, Cash and equivalents: $4.7BQ4'24, Long-term debt: $2.9BQ1'25, Cash and equivalents: $4.9BQ1'25, Long-term debt: $3.6BQ1'25Q2'25, Cash and equivalents: $4.5BQ2'25, Long-term debt: $3.4BQ3'25, Cash and equivalents: $4.2BQ3'25, Long-term debt: $3.7BQ3'25Q4'25, Cash and equivalents: $4.2BQ4'25, Long-term debt: $3.8BQ1'26, Cash and equivalents: $5.3BQ1'26, Long-term debt: $3.8BQ1'26Q2'26, Cash and equivalents: $5.0BQ2'26, Long-term debt: $3.8BQ3'26, Cash and equivalents: $4.5BQ3'26, Long-term debt: $3.8BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 22, 2026.

Molina Healthcare, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 22, 2026Q2 FY2026ended Jun 30, 2026filed Jul 23, 2026Q1 FY2026ended Mar 31, 2026filed Apr 23, 2026Q4 FY2025ended Dec 31, 2025filed Feb 10, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 11, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue11,08210,87410,79611,37511,47711,42711,14710,499−3.4%
Cost of revenue9,7199,4409,27010,13610,0449,8299,4799,003−3.2%
Gross profit—————————
Research and development—————————
Selling, general and administrative710724779795729711774665−2.6%
Operating income10614583(162)137373433380−22.6%
Other income (expense)—————————
Pretax income539129(214)88325390346−39.8%
Income tax153115(54)9709295+66.7%
Net income386014(160)79255298251−51.9%
Diluted EPS ($)0.731.190.27—1.514.755.45—−51.7%
Diluted shares (millions)525151—535455——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 22, 2026.

Molina Healthcare, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 22, 2026Q2 FY2026ended Jun 30, 2026filed Jul 23, 2026Q1 FY2026ended Mar 31, 2026filed Apr 23, 2026Q4 FY2025ended Dec 31, 2025filed Feb 10, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 11, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents4,4794,9855,3144,2484,2214,4994,8564,662+6.1%
Short-term investments4,1003,9303,9374,0084,2264,3104,4384,325−3.0%
Total current assets12,51412,92813,32612,44412,55213,11213,25712,773−0.3%
Total assets15,65216,00316,39115,56415,69816,20916,38615,630−0.3%
Total current liabilities7,3947,7008,1887,3727,4817,8768,1557,896−1.2%
Long-term debt3,7713,7693,7673,7663,6643,3753,5742,923+2.9%
Total liabilities11,49711,83212,31111,49511,50711,60612,07611,134−0.1%
Stockholders’ equity4,1554,1714,0804,0694,1914,6034,3104,496−0.9%
Shares outstanding (millions)5252525251545456—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 22, 2026.

Molina Healthcare, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 22, 2026Q2 FY2026ended Jun 30, 2026filed Jul 23, 2026Q1 FY2026ended Mar 31, 2026filed Apr 23, 2026Q4 FY2025ended Dec 31, 2025filed Feb 10, 2026Q3 FY2025ended Sep 30, 2025filed Oct 23, 2025Q2 FY2025ended Jun 30, 2025filed Jul 24, 2025Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025Q4 FY2024ended Dec 31, 2024filed Feb 11, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow(159)(294)1,082(298)(125)(302)190(224)−27.2%
Capital expenditures373027(1)38422211−2.6%
Free cash flow (CFO − capex)(196)(324)1,055(297)(163)(344)168(235)−20.2%
Depreciation and amortization3840394445584848−15.6%
Share repurchases00005000500500−100.0%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 10, 2026.

Income statement

Molina Healthcare, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 10, 2026FY2024ended Dec 31, 2024filed Feb 11, 2025FY2023ended Dec 31, 2023filed Feb 13, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 14, 2022FY2020ended Dec 31, 2020filed Feb 16, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Jul 27, 2011FY2009ended Dec 31, 2009filed Jul 27, 2011
Revenue45,42640,65034,07231,97427,77119,42316,82918,89019,88317,78214,1789,6676,5895,9144,5404,0863,669
Cost of revenue39,48834,42828,66927,17523,70415,82013,905——————————
Gross profit—————2,4792,3032,5181,8101,7251,5271,000843————
Research and development—————————————————
Selling, general and administrative3,0092,7432,4622,3112,0681,4801,2961,3331,5941,3931,146765666519393346276
Operating income7811,7071,5731,1731,0201,0781,0441,131(555)3063871931374113610552
Other income (expense)——(109)(110)(145)(117)(72)(132)(57)(101)(65)(58)(56)(18)(16)(16)—
Pretax income5891,5891,4641,063875961972999(612)20532213581231208938
Income tax117410373271216288235292(100)15317973361143357
Net income4721,1791,091792659673737707(512)52143625310215531
Diluted EPS ($)8.9220.4218.7713.5511.2511.2311.4710.61(9.07)0.922.581.291.130.210.451.320.79
Diluted shares (millions)53585859596064675656564847474642*39

Balance sheet

Molina Healthcare, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 10, 2026FY2024ended Dec 31, 2024filed Feb 11, 2025FY2023ended Dec 31, 2023filed Feb 13, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 14, 2022FY2020ended Dec 31, 2020filed Feb 16, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Jul 27, 2011FY2009ended Dec 31, 2009filed Jul 27, 2011
Cash and equivalents4,2484,6624,8484,0064,4384,1542,4522,8263,1862,8192,3291,539936796494456470
Short-term investments4,0084,3254,2593,4993,2021,8751,9461,6812,5241,7581,8011,019703343337295—
Total current assets12,44412,77312,54210,08410,0647,8765,9676,4627,5115,9885,3063,2032,0401,3491,048960—
Total assets15,56415,63014,89212,31412,2099,5326,7877,1548,4717,4496,5764,4352,9881,9351,6521,509—
Total current liabilities7,3727,8968,1686,8557,0474,9653,2694,2465,5574,5703,8222,1751,294828602566—
Long-term debt3,7662,9232,1802,1762,1732,1271,2371,0201,3189751,160690737262217164—
Total liabilities11,49511,13410,6779,3509,5797,4364,8275,5077,1345,8005,0193,4252,1101,153897790—
Stockholders’ equity4,0694,4964,2152,9642,6302,0961,9601,6471,3371,6491,5571,010893782755719—
Shares outstanding (millions)5256585858586162605756504645———

Cash flow statement

Molina Healthcare, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 10, 2026FY2024ended Dec 31, 2024filed Feb 11, 2025FY2023ended Dec 31, 2023filed Feb 13, 2024FY2022ended Dec 31, 2022filed Feb 13, 2023FY2021ended Dec 31, 2021filed Feb 14, 2022FY2020ended Dec 31, 2020filed Feb 16, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 26, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Mar 27, 2012FY2010ended Dec 31, 2010filed Jul 27, 2011FY2009ended Dec 31, 2009filed Jul 27, 2011
Operating cash flow(535)6441,6627732,1191,898434(314)8046731,1251,060190348225161155
Capital expenditures10110084917774573086176132115—————
Free cash flow (CFO − capex)(636)5441,5786822,0421,824377(344)718497993945—————
Depreciation and amortization19518617117613188891271781821261349479746138
Share repurchases1,0001,00004001286064700—005337028
Dividends paid—————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$100K
1 purchases by 1 insider; officers and directors $100K
Sold, twelve months
$4M
4 sales by 4 insiders; officers and directors $4M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Zoretic Richard CDirectorawardindirect304$180.85$55K9,693Oct 2, 2026
Oct 1, 2026Wolf Dale BDirectorawardindirect304$180.85$55K15,937Oct 2, 2026
Oct 1, 2026Schapiro Richard MDirectoraward304$180.85$55K12,615Oct 2, 2026
Oct 1, 2026Romney RonnaDirectorawardindirect304$180.85$55K18,173Oct 2, 2026
Oct 1, 2026Orlando Steven JDirectorawardindirect304$180.85$55K18,271Oct 2, 2026
Oct 1, 2026Lockhart Stephen HDirectoraward304$180.85$55K4,688Oct 2, 2026
Oct 1, 2026Grohowski Leo PDirectoraward304$180.85$55K1,846Oct 2, 2026
Oct 1, 2026Soistman Francis S JRDirectoraward304$180.85$55K1,211Oct 2, 2026
Oct 1, 2026Brasier Barbara LDirectoraward304$180.85$55K6,122Oct 2, 2026
Jul 1, 2026Zoretic Richard CDirectorawardindirect237$232.55$55K9,389Jul 2, 2026
Jul 1, 2026Wolf Dale BDirectorawardindirect237$232.55$55K15,633Jul 2, 2026
Jul 1, 2026Schapiro Richard MDirectoraward237$232.55$55K12,311Jul 2, 2026
Jul 1, 2026Romney RonnaDirectorawardindirect237$232.55$55K17,869Jul 2, 2026
Jul 1, 2026Orlando Steven JDirectorawardindirect237$232.55$55K17,967Jul 2, 2026
Jul 1, 2026Lockhart Stephen HDirectoraward237$232.55$55K4,384Jul 2, 2026
Jul 1, 2026Grohowski Leo PDirectoraward237$232.55$55K1,542Jul 2, 2026
Jul 1, 2026Soistman Francis S JRDirectoraward237$232.55$55K907Jul 2, 2026
Jul 1, 2026Brasier Barbara LDirectoraward237$232.55$55K5,818Jul 2, 2026
Jul 1, 2026Bacon DebraEVP, Medicaidtax withholding183$232.55$43K21,636Jul 2, 2026
Jun 30, 2026Woys JamesChief Operating Officeraward144$147.51$21K90,178Jul 2, 2026
Jun 30, 2026Barlow Jeff D.Chief Legal Officeraward138$147.51$20K67,313Jul 2, 2026
Jun 30, 2026Bacon DebraEVP, Medicaidaward23$147.51$3K21,819Jul 2, 2026
May 14, 2026Hebert MauriceChief Accounting Officeropen-market sale600$191.55$115K12,815May 15, 2026
May 11, 2026Barlow Jeff D.Chief Legal Officeropen-market sale17,811$186.12$3M67,175May 13, 2026
May 6, 2026Soistman Francis S JRDirectoraward170$197.44$34K670May 8, 2026

Full insider history for Molina Healthcare, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

2 of the tracked managers held MOH in their latest 13F filing, through August 13, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MOH by quarter.

FundManagerQuarterValueSharesWeightMove
Baupost GroupSeth KlarmanQ2 2026$145M633,6092.68%held
Scion Asset ManagementMichael BurryQ3 2025$24M125,0001.73%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
MOLINA HEALTHCARE, INC., CIK 1179929 on EDGAR
Extract generated
November 8, 2026
Withheld
9 line-years whose four quarters do not sum to the filed year: operating income FY2011, pretax income FY2011, buybacks FY2013, depreciation amortization FY2013, depreciation amortization FY2014, depreciation amortization FY2015, depreciation amortization FY2016, depreciation amortization FY2017, depreciation amortization FY2018
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/MOH.json